Full text is available at the source.
Abstract
Biological age may provide prognostic value beyond traditional risk scores in patients undergoing heart disease interventions.
- Traditional risk models like EuroSCORE II and STS-PROM show inconsistent performance in transcatheter cohorts.
- Accurate risk stratification is crucial for clinical decision-making prior to structural heart disease interventions.
- Biological age reflects cumulative physiological decline and may be a useful metric for assessing patient risk.
- Existing models were primarily designed for surgical patients, limiting their applicability to transcatheter interventions.
Simplified